Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. USPH
stocks logo

USPH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
200.10M
+10.89%
0.672
+31.8%
197.21M
+7.3%
0.563
+17.36%
208.36M
+5.58%
0.893
+10.29%
Estimates Revision
The market is revising Upward the revenue expectations for U.S. Physical Therapy, Inc. (USPH) for FY2025, with the revenue forecasts being adjusted by 0.82% over the past three months. During the same period, the stock price has changed by -10.91%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.82%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-4.21%
In Past 3 Month
Stock Price
Go Down
down Image
-10.91%
In Past 3 Month
Wall Street analysts forecast USPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for USPH is 106.50 USD with a low forecast of 103.00 USD and a high forecast of 110.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast USPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for USPH is 106.50 USD with a low forecast of 103.00 USD and a high forecast of 110.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 76.300
sliders
Low
103.00
Averages
106.50
High
110.00
Current: 76.300
sliders
Low
103.00
Averages
106.50
High
110.00
JPMorgan
Benjamin Rossi
Overweight
downgrade
$110 -> $100
2025-11-24
Reason
JPMorgan
Benjamin Rossi
Price Target
$110 -> $100
2025-11-24
downgrade
Overweight
Reason
JPMorgan analyst Benjamin Rossi lowered the firm's price target on U.S. Physical Therapy to $100 from $110 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q3 report.
JPMorgan
Benjamin Rossi
Overweight
initiated
$110
2025-09-18
Reason
JPMorgan
Benjamin Rossi
Price Target
$110
2025-09-18
initiated
Overweight
Reason
JPMorgan analyst Benjamin Rossi assumed coverage of U.S. Physical Therapy with an Overweight rating and $110 price target. The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. The analyst believes U.S. Physical Therapy is well positioned to benefit from long-term demographic trends.
Barrington
analyst
Outperform
maintain
$98 -> $103
2025-08-08
Reason
Barrington
analyst
Price Target
$98 -> $103
2025-08-08
maintain
Outperform
Reason
Barrington raised the firm's price target on U.S. Physical Therapy to $103 from $98 and keeps an Outperform rating on the shares. Q2 revenue "exceeded our Street-high estimate" and adjusted EPS also came in "well above" the firm's expectation and consensus, notes the analyst, who raising the firm's 2025 and 2026 adjusted EBITDA estimates following the report.
JMP Securities
Constantine Davides
Buy
Reiterates
$113
2025-04-22
Reason
JMP Securities
Constantine Davides
Price Target
$113
2025-04-22
Reiterates
Buy
Reason
JP Morgan
Calvin Sternick
Buy
Maintains
$120 → $110
2025-03-19
Reason
JP Morgan
Calvin Sternick
Price Target
$120 → $110
2025-03-19
Maintains
Buy
Reason
JPMorgan lowered the firm's price target on U.S. Physical Therapy to $110 from $120 and keeps an Overweight rating on the shares. Following Q4 earnings, the firm is updating its estimates, noting that for 2025 it increased its revenue estimate to $747M while bringing down its adjusted EBITDA estimate to $91M. For 2026, the firm increased its revenue estimate to $794M while maintaining its adjusted EBITDA estimate at $101M, the analyst added.
Barrington Research
Michael Petusky
Buy
Maintains
$108 → $98
2025-02-28
Reason
Barrington Research
Michael Petusky
Price Target
$108 → $98
2025-02-28
Maintains
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for US Physical Therapy Inc (USPH.N) is 27.04, compared to its 5-year average forward P/E of 34.88. For a more detailed relative valuation and DCF analysis to assess US Physical Therapy Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
34.88
Current PE
27.04
Overvalued PE
39.69
Undervalued PE
30.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
20.79
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
23.37
Undervalued EV/EBITDA
18.21

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.24
Current PS
0.00
Overvalued PS
2.75
Undervalued PS
1.73
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

USPH News & Events

Events Timeline

(ET)
2025-11-05
17:16:16
U.S. Physical Therapy announces Q3 operating EPS of 66 cents, matching expectations.
select
2025-08-01 (ET)
2025-08-01
07:34:57
U.S. Physical Therapy acquires physical therapy practice, terms undisclosed
select
2025-05-28 (ET)
2025-05-28
16:14:08
U.S. Physical Therapy announces dual listing on NYSE Texas
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
12-04NASDAQ.COM
YieldBoost U.S. Physical Therapy Increases from 2.4% to 15.6% Through Options Strategy

  • Dividend Predictability: Dividend amounts for companies like U.S. Physical Therapy, Inc. are influenced by profitability and historical trends, making future dividends uncertain, though a 2.4% annualized yield is currently expected.

  • Options Trading Insights: The stock's historical volatility of 34% and trading history can inform decisions on selling covered calls, particularly at the $80 strike price, balancing potential rewards against risks.

  • Current Market Activity: On a recent trading day, S&P 500 options showed a put volume of 859,694 contracts and call volume of 1.62 million, indicating a strong preference for call options among traders.

  • Author's Perspective: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.

[object Object]
Preview
5.0
11-25Yahoo Finance
US Physical Therapy Insider Acquires $276,000 in Shares, Recent SEC Filing Reveals

  • Transaction Details: Kathleen A Gilmartin, the Director, executed a purchase of 4,000 shares in US Phy on November 20, 2025.

  • Access Requirement: Users need to sign in to access their portfolio information.

[object Object]
Preview
9.5
11-09Yahoo Finance
Highlights from US Physical Therapy Inc (USPH) Q3 2025 Earnings Call: Record Number of Patient Visits and More

  • Revenue Growth: US Physical Therapy Inc reported a 17.8% increase in revenue to $168.1 million in Q3 2025, with total patient visits rising by 18% year over year, supported by the addition of 84 new clinics.

  • Operational Performance: The company achieved a record high of 32.2 visits per clinic per day, while gross profit increased by 30%, indicating effective cost management despite challenges like Medicare reimbursement cuts.

  • Strategic Focus: USPH is prioritizing acquisitions in the Injury Prevention segment over share buybacks due to better growth prospects, while also investing in AI-driven documentation to enhance efficiency.

  • Market Dynamics: The competitive landscape remains stable, with consistent demand for physical therapy services, although recruitment and retention efforts have improved to address market challenges.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is US Physical Therapy Inc (USPH) stock price today?

The current price of USPH is 76.3 USD — it has increased 1.18 % in the last trading day.

arrow icon

What is US Physical Therapy Inc (USPH)'s business?

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 774 outpatient physical therapy clinics in 44 states. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre and post operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.

arrow icon

What is the price predicton of USPH Stock?

Wall Street analysts forecast USPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for USPH is 106.50 USD with a low forecast of 103.00 USD and a high forecast of 110.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is US Physical Therapy Inc (USPH)'s revenue for the last quarter?

US Physical Therapy Inc revenue for the last quarter amounts to 197.13M USD, increased 17.32 % YoY.

arrow icon

What is US Physical Therapy Inc (USPH)'s earnings per share (EPS) for the last quarter?

US Physical Therapy Inc. EPS for the last quarter amounts to 0.48 USD, increased 23.08 % YoY.

arrow icon

What changes have occurred in the market's expectations for US Physical Therapy Inc (USPH)'s fundamentals?

The market is revising Upward the revenue expectations for U.S. Physical Therapy, Inc. (USPH) for FY2025, with the revenue forecasts being adjusted by 0.82% over the past three months. During the same period, the stock price has changed by -10.91%.
arrow icon

How many employees does US Physical Therapy Inc (USPH). have?

US Physical Therapy Inc (USPH) has 4034 emplpoyees as of December 05 2025.

arrow icon

What is US Physical Therapy Inc (USPH) market cap?

Today USPH has the market capitalization of 1.16B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free